FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

7662911000001107: Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
20599501000001110 Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
49775501000001118 Glycophos 4.32g/20ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Sodium glycerophosphate true Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Has specific active ingredient Sodium glycerophosphate pentahydrate true Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Is a Sodium glycerophosphate 4.32g/20ml solution for injection vials false Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Has active ingredient Sodium glycerophosphate true Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Is a Glycophos true Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Is a Sodium glycerophosphate 4.32g solution for injection 20mL vial false Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Has specific active ingredient Sodium glycerophosphate false Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Is a Sodium glycerophosphate 4.32g/20ml solution for infusion vials false Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Is a Sodium glycerophosphate 4.32g/20ml solution for infusion vials true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) 10 vial Is pack of False Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) 1 vial Is pack of False Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Inferred relationship Existential restriction modifier
Glycophos 4.32g/20ml concentrate for solution for infusion vials (Fresenius Kabi Ltd) 1 vial Has AMP True Glycophos 4.32g/20ml solution for injection vials (Fresenius Kabi Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start